Middle East & Africa Non Invasive Prenatal Testing Market Size & Outlook
Middle East & Africa non invasive prenatal testing market, 2018-2030 (US$M)
Related Markets
MEA non invasive prenatal testing market highlights
- The MEA non invasive prenatal testing market generated a revenue of USD 118.7 million in 2022.
- The market is expected to grow at a CAGR of 10.3% from 2023 to 2030.
- In terms of segment, 13-24 weeks was the largest revenue generating gestation period in 2022.
- 0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 118.7 million |
| Market revenue in 2030 | USD 260.1 million |
| Growth rate | 10.3% (CAGR from 2022 to 2030) |
| Largest segment | 13-24 weeks |
| Fastest growing segment | 0-12 weeks |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
| Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.1% of the global non invasive prenatal testing market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,631.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non Invasive Prenatal Testing Market Scope
Non Invasive Prenatal Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa non invasive prenatal testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 52.15% in 2022. Horizon Databook has segmented the Middle East & Africa non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa has a high prevalence of chromosomal abnormalities owing to high number of consanguineous marriages. Furthermore, the number of these marriages is growing in nations such as Yemen, UAE, and Qatar. According to the Centre for Arab Genomic Studies, Down syndrome is one of the most common chromosomal abnormalities in the Middle East and impacts 1 in 800 births in the region. The high prevalence of chromosomal abnormalities is anticipated to drive the market in the region. However, uncertain reimbursement scenarios, weak healthcare infrastructure, and low affordability of tests in some countries of the MEA are expected to be major threats to market growth.
Reasons to subscribe to Middle East & Africa non invasive prenatal testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa non invasive prenatal testing market databook
-
Our clientele includes a mix of non invasive prenatal testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa non invasive prenatal testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA non invasive prenatal testing market size, by country, 2018-2030 (US$M)
Middle East & Africa Non Invasive Prenatal Testing Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
